Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
152.50    2.10 (1.40%)
Bid:
150.50
Ask:
151.70
Spread: 1.20 (0.797%)
Market Cap: £1.58b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Director/PDMR Shareholding

12 Aug 2025 14:41

RNS Number : 0382V
Currys PLC
12 August 2025
 

12 August 2025

CURRYS PLC

NOTIFICATION OF TRANSACTION OF DIRECTOR

Award under the 2022/23 Deferred Share Bonus Plan ("DSBP")

In accordance with the requirements of DTR 3.1 and Market Abuse Regulation Article 19, Currys plc (the 'Company') announces the following share transaction undertaken by Alex Baldock, Group Chief Executive (a PDMR).

Alex Baldock exercised nil cost options over ordinary shares of 0.1 pence in the Company in respect of the 2022/23 DSBP Award (the "Award") which was granted on the 3 August 2023 under the DSBP. The Award vested on 3 August 2025, and Alex subsequently exercised a total of 288,617 options and sold 136,128 shares to cover the tax liability arising on the transaction. The remaining 152,489 shares were retained.

PMDR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alex Baldock

2

Reason for the notification

a)

Position/status

Group Chief Executive

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Currys plc

b)

LEI

2138001E12GWLLDQQF16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of 0.1p each in Currys plc

Identification code

GB00B4Y7R145

b)

Nature of the transaction

Exercise of a share option under the Currys Deferred Share Bonus Plan and sale of shares to cover the tax and NIC arising from the exercise.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

288,617

£1.131

136,128

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

288,617

 £0.00

 

2. Sale

Price(s)

Volume(s)

Total

£1.131

136,128

 £153,961

e)

Date of the transaction

(DD-MM-YYYY)

12-08-2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

 

Sarah Thomas Deputy Company Secretary +44 (0)7401 373 188

 

Dan Homan Investor Relations Director +44 (0)7401 400 442

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDIGSBDGUD
Date   Source Headline
3rd Jun 20267:00 amRNSFredrik Tønnesen appointed Group Chief Executive
1st Jun 20269:36 amRNSTotal Voting Rights
19th May 202611:09 amRNSDirector Declaration
19th May 20267:00 amRNSPerformance continues to strengthen
12th May 20264:56 pmRNSHolding(s) in Company
11th May 202612:04 pmRNSHolding(s) in Company
1st May 20264:34 pmRNSTotal Voting Rights
1st May 20264:31 pmRNSHolding(s) in Company
30th Apr 202610:01 amRNSHolding(s) in Company
14th Apr 202610:56 amRNSHolding(s) in Company
13th Apr 20269:34 amRNSHolding(s) in Company
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:31 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20269:20 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20268:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:29 pmRNSHolding(s) in Company
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSAlex Baldock to step down as Group Chief Executive
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20262:25 pmRNSHolding(s) in Company
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20269:15 amRNSHolding(s) in Company
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202610:03 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 202610:43 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.